Apnimed will be waiting for the readout from a second Phase III trial before it ...
In April 2025, the European Medicines Agency (EMA) approved Eisai and Biogen’s L...
The US FDA has approved Incyte’s Zynyz (retifanlimab-dlwr) in conjunction with c...
Pfizer has signed a worldwide licensing agreement, excluding China, with biophar...
Tezepelumab demonstrated clinically relevant benefits in specific inflammatory s...
At ATS 2025, data from the Phase III MATINEE trial reinforced the efficacy of Nu...
At a recent gathering, experts in the Swiss biotech and pharma sector underscore...
The sale brings attention back to privacy concerns as Regeneron now controls gen...
The Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) ...
Experts predict growing pains as the life sciences sector moves to adapt to the ...
US President Donald Trump has resurrected a drug pricing plan that equates to In...
The US Food and Drug Administration has granted approval to Amneal Pharmaceutica...
The executive order instructs the FDA to expedite the approval process for domes...
A record number of biosimilars were approved by the FDA in 2024, with 2025 set t...
